Hims & Hers Health Inc (HIMS) Stock Analysis

Verdict: AVOID

Starkes Skalierungstempo trifft auf erhebliche Fehlschläge beim Gewinn je Aktie sowie regulatorischen Druck durch FTC und FDA.

Investment score: 39/100

Analysis as of

Is Hims & Hers Health Inc stock worth reviewing? AI model thesis

Der Modellscore von 39/100 liegt im Bereich MEIDEN. Die zentrale These und die Faktoraufschlüsselung erläutern die Bewertung.

7-factor investment score

Hims & Hers Health Inc opportunities and risks

What speaks for HIMS

What speaks against HIMS

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
HIMSn/a2.7xn/a64.7%-5.5%1.3%
GHn/a19.0xn/a65.0%-38.3%-1.1%
LH25.6x1.8x15.0x27.8%7.0%4.5%
BTSG44.6x0.9x22.5x12.4%2.0%3.2%
DVA15.4x0.8x7.8x31.0%6.0%14.0%
HNGE76.4x11.1x74.2x84.5%15.1%3.6%
Peer median25.6x1.8x15.0x31.0%6.0%3.6%

Frequently asked questions about Hims & Hers Health Inc (HIMS)

Is HIMS stock a good investment?

The cached TradeMates AI model rates Hims & Hers Health Inc as AVOID with an investment score of 39/100. Der Modellscore von 39/100 liegt im Bereich MEIDEN. Die zentrale These und die Faktoraufschlüsselung erläutern die Bewertung. This is algorithmic model output, not personal investment advice.

Is HIMS stock a buy?

The TradeMates model verdict for HIMS is AVOID with an investment score of 39/100. Treat this as a model signal to review, not a personal buy recommendation.